Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Peroxiredoxin 6 (Prdx6) Is Associated with Changes in Autophagy in Myeloid and Non-Myeloid Cells

Michael Ellison, PhD, Gail Thurman, BA, Daniel R. Ambruso, MD

Blood (2014) 124 (21): 1407.

https://doi.org/10.1182/blood.V124.21.1407.1407

Published: 2014

Journal Articles

Myeloid Cells Differentiated in the Presence of Interferon-γ (INF-γ) Compared to Mature Cells Exposed to This Cytokine Exhibit Different Phox Protein Expression and Nox2 Activity

Michael Ellison, PhD, Gail Thurman, BA, Daniel R. Ambruso, MD

Blood (2014) 124 (21): 4103.

https://doi.org/10.1182/blood.V124.21.4103.4103

Published: 2014

Journal Articles

Peroxiredoxin 6 Enhances Phagocyte NADPH Oxidase (phox) Activity in Response to Agonists Acting Via Cell Surface Receptors and Intracellular Signaling Pathways.

Michael A. Ellison, PhD, Daniel R. Ambruso, MD, Gail Thurman, BS

Blood (2012) 120 (21): 2139.

https://doi.org/10.1182/blood.V120.21.2139.2139

Published: 2012

Journal Articles

Neutrophil p29 Peroxiredoxin 6/aiPLA2 (p29 Prdx6) Enhances Superoxide Anion (O 2 - ) Production by Nox2: Role for the PLA2 Active Site

Daniel R Ambruso, MD, Michael Ellison, PhD, Gail Thurman, BS

Blood (2010) 116 (21): 926.

https://doi.org/10.1182/blood.V116.21.926.926

Published: 2010

Journal Articles

Neutrophil p29 Peroxiredoxin VI/aiPLA2 (p29 Prdx VI) Enhances Superoxide Production by the NADPH Oxidase in a Manner Dependent On the PLA2 Active Site.

Michael Ellison, Gail Thurman, Daniel R. Ambruso, MD

Blood (2009) 114 (22): 3592.

https://doi.org/10.1182/blood.V114.22.3592.3592

Published: 2009

Journal Articles

Neutrophil p29 Peroxiredoxin VI (Prdx VI) Enhances Bactericidal Activity and Chemotaxis in Myeloid Cells.

Michael Ellison, Gail Thurman, Daniel R. Ambruso, MD

Blood (2009) 114 (22): 1354.

https://doi.org/10.1182/blood.V114.22.1354.1354

Published: 2009

Journal Articles

Mirasol™ Pathogen Reduction of Packed Red Blood Cells (PRBCs) and Apheresis Platelet (Aplt) Concentrates Decreases Neutrophil Priming Activity Generated during Storage.

Daniel R. Ambruso, Gail Thurman, Susanne Marschner, Ray Goodrich

Blood (2007) 110 (11): 2893.

https://doi.org/10.1182/blood.V110.11.2893.2893

Published: 2007

Journal Articles

Knockdown of Peroxiredoxin VI in K562 Cells Stably Transfected with Oxidase Components Reduces NADPH Oxidase Activity in Response to PMA and fMLP.

Daniel R. Ambruso, Gail Thurman

Blood (2007) 110 (11): 2416.

https://doi.org/10.1182/blood.V110.11.2416.2416

Published: 2007

Journal Articles

Knockdown of Neutrophil p29 Peroxiredoxin (Prx) in Transgenic K562 Cells Expressing Phox Proteins Results in Diminished Oxidase Activity.

Daniel R. Ambruso, MD, Gail Thurman

Blood (2006) 108 (11): 1643.

https://doi.org/10.1182/blood.V108.11.1643.1643

Published: 2006

Journal Articles

Complement Activation in Transfusion Related Acute Lung Injury (TRALI).

Daniel R. Ambruso, MD, Christopher C. Silliman, MD, PhD, Marguerite Kelher, Gail Thurman, Patsy Giclas, PhD

Blood (2006) 108 (11): 954.

https://doi.org/10.1182/blood.V108.11.954.954

Published: 2006

Journal Articles

Antioxidant Effects of Neutrophil p29 Peroxiredoxin.

Daniel R. Ambruso, Gail Thurman, Carolina Gonzalez-Aller

Blood (2005) 106 (11): 3087.

https://doi.org/10.1182/blood.V106.11.3087.3087

Published: 2005

Journal Articles

Cysteine Residues on Neutrophil p29 Peroxiredoxin Are Required for Enhanced Oxidase Activity.

Daniel R. Ambruso, MD, Gail Thurman, Carolina Gonzalez-Aller

Blood (2004) 104 (11): 654.

https://doi.org/10.1182/blood.V104.11.654.654

Published: 2004

Journal Articles

In Vivo Treatment With Granulocyte Colony-Stimulating Factor Results in Divergent Effects on Neutrophil Functions Measured In Vitro

Patrick J. Leavey, Karen S. Sellins, Gail Thurman, David Elzi, Andrew Hiester, Christopher C. Silliman, Gary Zerbe, J. John Cohen, Daniel R. Ambruso

Blood (1998) 92 (11): 4366–4374.

https://doi.org/10.1182/blood.V92.11.4366

Published: 1998

NARROW

Peroxiredoxin 6 (Prdx6) Is Associated with Changes in Autophagy in Myeloid and Non-Myeloid Cells

Myeloid Cells Differentiated in the Presence of Interferon-γ (INF-γ) Compared to Mature Cells Exposed to This Cytokine Exhibit Different Phox Protein Expression and Nox2 Activity

Peroxiredoxin 6 Enhances Phagocyte NADPH Oxidase (phox) Activity in Response to Agonists Acting Via Cell Surface Receptors and Intracellular Signaling Pathways.

Neutrophil p29 Peroxiredoxin 6/aiPLA2 (p29 Prdx6) Enhances Superoxide Anion (O 2 - ) Production by Nox2: Role for the PLA2 Active Site

Neutrophil p29 Peroxiredoxin VI/aiPLA2 (p29 Prdx VI) Enhances Superoxide Production by the NADPH Oxidase in a Manner Dependent On the PLA2 Active Site.

Neutrophil p29 Peroxiredoxin VI (Prdx VI) Enhances Bactericidal Activity and Chemotaxis in Myeloid Cells.

Mirasol™ Pathogen Reduction of Packed Red Blood Cells (PRBCs) and Apheresis Platelet (Aplt) Concentrates Decreases Neutrophil Priming Activity Generated during Storage.

Knockdown of Peroxiredoxin VI in K562 Cells Stably Transfected with Oxidase Components Reduces NADPH Oxidase Activity in Response to PMA and fMLP.

Knockdown of Neutrophil p29 Peroxiredoxin (Prx) in Transgenic K562 Cells Expressing Phox Proteins Results in Diminished Oxidase Activity.

Complement Activation in Transfusion Related Acute Lung Injury (TRALI).

Antioxidant Effects of Neutrophil p29 Peroxiredoxin.

Cysteine Residues on Neutrophil p29 Peroxiredoxin Are Required for Enhanced Oxidase Activity.

In Vivo Treatment With Granulocyte Colony-Stimulating Factor Results in Divergent Effects on Neutrophil Functions Measured In Vitro

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only